Shenzhen New Industries Biomedical Cash Flow-to-Debt Ratio
Shenzhen New Industries Biomedical cash flow-to-debt ratio. Shenzhen New Industries Biomedical (300832) has a Cash Flow-to-Debt Ratio of 0.73x as of September 2025, meaning its operating cash flow of CN¥606.21 Million could theoretically repay 1% of its total liabilities (CN¥831.98 Million) in one year. Check 300832 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shenzhen New Industries Biomedical (2012–2024)
Cash flow-to-debt ratio of Shenzhen New Industries Biomedical from 2012 to 2024. Historical debt coverage capacity for Shenzhen New Industries Biomedical across 13 annual periods. Check 300832 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Shenzhen New Industries Biomedical Cash Flow-to-Debt Ratio by Year (2012–2024)
Shenzhen New Industries Biomedical cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for Shenzhen New Industries Biomedical. For the full cash flow conversion analysis, see Shenzhen New Industries Biomedical operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.30x | CN¥1.36 Billion | CN¥1.04 Billion | ▼ -37.8% |
| 2023 | 2.09x | CN¥1.42 Billion | CN¥678.09 Million | ▲ +33.7% |
| 2022 | 1.56x | CN¥962.39 Million | CN¥615.06 Million | ▲ +5.9% |
| 2021 | 1.48x | CN¥773.22 Million | CN¥523.51 Million | ▼ -24.2% |
| 2020 | 1.95x | CN¥976.65 Million | CN¥501.49 Million | ▼ -25.3% |
| 2019 | 2.61x | CN¥831.73 Million | CN¥318.92 Million | ▲ +2.0% |
| 2018 | 2.56x | CN¥701.97 Million | CN¥274.52 Million | ▲ +21.8% |
| 2017 | 2.10x | CN¥524.73 Million | CN¥250.00 Million | ▼ -19.9% |
| 2016 | 2.62x | CN¥486.81 Million | CN¥185.75 Million | ▲ +7.0% |
| 2015 | 2.45x | CN¥305.93 Million | CN¥124.94 Million | ▲ +30.3% |
| 2014 | 1.88x | CN¥253.47 Million | CN¥134.92 Million | ▲ +120.2% |
| 2013 | 0.85x | CN¥138.33 Million | CN¥162.12 Million | ▼ -0.7% |
| 2012 | 0.86x | CN¥55.80 Million | CN¥64.93 Million | — |